SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-003232
Filing Date
2022-03-09
Accepted
2022-03-09 16:25:00
Documents
12
Period of Report
2022-03-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K kldo-20220309.htm   iXBRL 8-K 44579
  Complete submission text file 0000950170-22-003232.txt   160927

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kldo-20220309.xsd EX-101.SCH 2492
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kldo-20220309_lab.xml EX-101.LAB 13438
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kldo-20220309_pre.xml EX-101.PRE 9934
6 EXTRACTED XBRL INSTANCE DOCUMENT kldo-20220309_htm.xml XML 4695
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38822 | Film No.: 22725678
SIC: 2836 Biological Products, (No Diagnostic Substances)